EVP & Chief Administrative, Legal and Business Development Officer through March 1, 2021 · Vertex Pharmaceuticals Inc (VRTX)

Michael Parini

A named executive officer of Vertex Pharmaceuticals in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$6,355,678

Salary $830,769Stock awards $4,375,585

FY2019: $6,039,497

5th of 6 named executive officers at Vertex Pharmaceuticals by FY2020 total.

6 named officers on file for Vertex Pharmaceuticals, FY2020

Michael Parini’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • VRTX’s disclosed peer group of 12 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Vertex Pharmaceuticals’s whole pay program stands against its peers

  • Vertex Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VRTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2021 (DEF 14A).

Free

Get Michael Parini’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Parini compensation by year

Vertex Pharmaceuticals Summary Compensation Table · all 5 fiscal years held
In US dollars, as Vertex Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$517,846$694,519$746,923$785,481$830,769
Bonus$250,000$0$0$0$0
Stock awards$1,689,672$3,150,020$2,625,244$2,679,897$4,375,585
Option awards$4,731,100$1,332,316$1,136,785$1,312,509$0
Non-equity incentive$499,867$788,655$834,384$1,218,000$1,081,920
Pension and deferred compensation$0$0$0$0$0
All other$41,779$13,110$29,000$43,610$67,404
Total$7,730,264$5,978,620$5,372,336$6,039,497$6,355,678

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vertex Pharmaceuticals Inc DEF 14A filed April 8, 2021, accession 0001308179-21-000196, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vertex Pharmaceuticals Inc filed document, accession 0001308179-21-000196. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2021.

$7.7M
$6.0M
$5.4M
$6.0M
$6.4M
FY16
FY17
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU10,323$2,439,738—
RSU10,323$2,439,738—
RSU5,444$1,286,635—
PSU5,444$1,286,635—
PSU5,162$1,219,987—
PSU5,162$1,219,987—
PSU5,162$1,219,987—
PSU4,219$997,118—
PSU4,083$964,976—
PSU2,814$665,061—
RSU2,813$664,824—
Option2,330—$86.52

Per the Outstanding Equity Awards at Fiscal Year-End table in Vertex Pharmaceuticals Inc's FY2020 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 14 award rows shown.

Vertex Pharmaceuticals’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jeffrey LeidenExecutive Chairman (CEO and President through March 31, 2020)$16,473,245
Reshma KewalramaniCEO and President (EVP & Chief Medical Officer through March 31, 2020)$9,111,359
Stuart ArbuckleEVP & Chief Commercial and Operations Officer$7,282,978
David AltshulerEVP & Global Research and Chief Scientific Officer$7,060,584
Michael Parini · this pageEVP & Chief Administrative, Legal and Business Development Officer through March 1, 2021$6,355,678
Charles WagnerEVP & Chief Financial Officer$6,090,390

The full Vertex Pharmaceuticals compensation record

free company brief

This page is one person within Vertex Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Vertex Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vertex Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Parini's compensation dossier · One-time report. No refunds.